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Targeting of AID to antibody variable (V) regions results in somatic hypermutation, whereas its
recruitment to switch (S) regions leads to class-switch recombination. Yeap et al. find that the
mechanism by which variable and switch regions recruit AID essentially is the same but that the
two regions differ in the density of double-stranded DNA breaks that are generated. These lead
to either point mutations in V exons in somatic hypermutation or deletion of intervening DNA
sequences during class switch recombination.During the developmental progression of
B-lineage cells, antibody genes are be-
ing assembled by unique combinations
of gene segments encoding for variable
(V), diversity (D), and joining (J) elements,
a process frequently referred to as V(D)J
recombination. In the primary lymphoid
organs such as the fetal liver and the
bone marrow, VDJ recombination ulti-
mately leads to a diverse antibody reper-
toire expressed on the cell surface of
the antigen-inexperienced mature B
cell population. Upon expression of an
innocuous B cell receptor (BCR), naive
B cells exit the primary lymphoid organs
and migrate to the spleen and lymph no-
des. Once exposed to invading patho-
gens, B cells move to specialized micro-
anatomical structures, named germinal
centers. Here, B cells are subject to
two distinct sets of genomic modifica-
tions: class switch recombination (CSR)
and/or somatic hypermutation (SHM)
(Chandra et al., 2015). Somatic point mu-
tations in germinal center B cells that
lead to increased affinity of the antigen
receptor are selected for further matura-
tion, while mutations that lead to a
decline in antigen receptor affinity are
being depleted within the population.
Frequently, but not exclusively, CSR is
also initiated in the germinal centers
and can be induced in vitro by culturing
naive B cells in the presence of the
appropriate stimuli. During CSR, dsDNA
breaks are generated at highly repetitive
sequences, named S regions, that are
located adjacent to exons encoding for
the ensemble of antibody isotypes.
DNA breaks generated during CSR findeach other through thermal motion, lead-
ing to the joining of two S regions that
replace the IgM constant region with
that of other isotypes, including IgG,
IgE, or IgA. Ultimately, this highly orches-
trated series of genomic changes gener-
ates a population of effector B cells with
distinct functions that express a diverse
and high-affinity antibody repertoire.
The process of SHM and CSR requires
activation-induced cytidine deaminase
(AID). AID converts cytosine (C) into uracil
(U), leading to DNA lesions (Muramatsu
et al., 2007; Di Noia and Neuberger,
2007). Such DNA lesions generate dou-
ble-stranded DNA breaks across switch
regions or point mutations that are associ-
ated with exons encoding for V regions
(Nussenzweig and Nussenzweig, 2010;
Alt et al., 2013). Distinct DNA repair mod-
ules are used to repair and modify the
DNA lesions, including mismatch DNA
repair, base excision repair, and error-
prone DNA polymerases.
AID predominantly, but not exclusively,
targets RGYW consensus sequences (R
relates to purine, Y to pyrimidine, W to A
or T) (Hackney et al., 2009). The RGYW
motif is enriched, albeit modestly, across
the majority of the V region repertoire.
The RGYWsequence is found in S regions
more densely than within V exons. The
high density of the RGYW consensus se-
quences at S regions and its palindromic
nature permit the targeting of AID to
both the sense and anti-sense DNA
strands across the S regions (Zarrin
et al., 2004). This then leads to double-
stranded breaks and deletion of the inter-
vening genomic sequences.Cell 163, NoThe RGWY motif (Figure 1) is not res-
tricted to V exons. Rather it is present
at other locations in the genome that
are not subjected to AID targeting. If
it is not specific to V exons and S regions,
then what is the role of the RGYW motif
in AID targeting? Furthermore, is the
role of the RGWY motif equivalent to
promote class switch recombination and
somatic hypermutation? In this issue
of Cell, Yeap et al. (2015) have designed
an elegant experimental approach to
address this question. Briefly, a strategy
was developed to measure AID activity
on a spectrum of test sequences, named
passenger alleles. This assay permits
the testing of a passenger against a V
exon expressing a productive in-frame
antibody allele in the same normal V-re-
gion genomic location and with the
same transcriptional machinery (known
to target AID). The mutations associated
with passenger alleles were then com-
pared to the sequences of a productive
V region known to interact with a specific
antigen, termed 4-hyroxy-3-nitrophe-
nyacteyl (NP). This approach was com-
bined with throughput DNA sequencing
that permitted ‘‘surrogate kinetic’’ ana-
lyses of somatic mutations in both pro-
ductive and passenger alleles. Further-
more, in the approach developed by
Yeap et al. (2015), selection for NP does
not occur within the time-frame that
spans the short-term immunization proto-
cols and that the passenger allele is not
translated, and consequently, there is no
bias by selection for antigen or against
mutations that inactive the antibody.
Interestingly, the authors found that AIDvember 19, 2015 ª2015 Elsevier Inc. 1055
Figure 1. Schematic Diagram Depicting the Role of the RGYW Motif in Class-Switch
Recombination and Somatic Hypermutation
Adapted and modified from Chandra et al. (2015).acted on the most dominant RGYW tar-
gets in V exons and S regions, pointing
to a conserved mechanism by which AID
activates class switch recombination or
somatic hypermutation. Given this strik-
ing similarity, the authors next addressed
why targeting to V exons would yield point
mutations rather than genomic deletions
observed during class switch recombina-
tion. Using their reporter system, Yeap
et al. (2015) observed that, surprisingly,
somatic hypermutation did in fact lead to
double-stranded breaks and genomic de-
letions in V exons, similar to class switch
recombination process. Thus, no special-
izedmechanism is required for generating1056 Cell 163, November 19, 2015 ª2015 Elsdeletions that have been observed in sub-
sets of antibodies, including those in
neutralizing antibodies isolated from pa-
tients infected with HIV. These findings
are intriguing, suggesting that the ability
of S regions to be subjected to double-
stranded breaks with limited AID expo-
sure may have evolved to permit efficient
class switch recombination, avoiding mu-
tations associated with V regions that, in
principle, could affect antibody affinity
and/or specificity.
These data also provide insight into the
special nature of V exons compared to
other regions in the genome as it relates
to being targeted by AID (Odegard andevier Inc.Schatz, 2006). The authors found that
non-Ig DNA sequences, including bacte-
rial DNA, that were inserted as passen-
gers V-region location accumulated point
mutations at RGWY sequences at levels
similar to V exons. Thus, it is the genomic
location, exons encoding for V regions,
that matter for AID targeting. A wide spec-
trum of possible mechanisms has been
proposed, including AID recruitment mo-
tifs distinct from that of the RGYW motif,
enhancer activity, and ongoing ncRNA
transcription. Now that Yeap et al. (2015)
have resolved the role of RGYW motifs
in AID targeting, the search begins to un-
derstand why and how the AID targeting
machinery senses genomic location.
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